Genomics

Dataset Information

0

Mechanistic study of Wee1 kinase inhibition with AZD1775 exposes drug targetable vulnerabilities in acute B-lymphoblastic leukemia [scRNA-seq]

ABSTRACT: Mechanistic study of Wee1 kinase inhibition with AZD1775 exposes drug targetable vulnerabilities in acute B-lymphoblastic leukemia [scRNA-seq]

PROVIDER: PRJNA904696 | ENA |

REPOSITORIES: ENA

Json Xml

Dataset's files

Source:
Action DRS
SRR22390217.fastq.gz Fastqsanger.gz
SRR22390218.fastq.gz Fastqsanger.gz
SRR22390219.fastq.gz Fastqsanger.gz
Items per page:
1 - 3 of 3

Similar Datasets

Genomics Mechanistic study of Wee1 kinase inhibition with AZD1775 exposes drug targetable vulnerabilities in acute B-lymphoblastic leukemia
| PRJNA908814 | ENA
Genomics Mechanistic study of Wee1 kinase inhibition with AZD1775 exposes drug targetable vulnerabilities in acute B-lymphoblastic leukemia [GROseq]
| PRJNA908801 | ENA
Genomics Mechanistic study of Wee1 kinase inhibition with AZD1775 exposes drug targetable vulnerabilities in acute B-lymphoblastic leukemia [scMultiome]
| PRJNA908817 | ENA
Genomics Mechanistic study of Wee1 kinase inhibition with AZD1775 exposes drug targetable vulnerabilities in acute B-lymphoblastic leukemia [scATAC-seq]
2023-05-14 | GSE218805 | GEO
Transcriptomics Mechanistic study of Wee1 kinase inhibition with AZD1775 exposes drug targetable vulnerabilities in acute B-lymphoblastic leukemia [scMultiome]
2023-05-14 | GSE220112 | GEO
Transcriptomics Mechanistic study of Wee1 kinase inhibition with AZD1775 exposes drug targetable vulnerabilities in acute B-lymphoblastic leukemia [scRNA-seq]
2023-05-14 | GSE218621 | GEO
Genomics Mechanistic study of Wee1 kinase inhibition with AZD1775 exposes drug targetable vulnerabilities in acute B-lymphoblastic leukemia [scATAC-seq]
| PRJNA905534 | ENA
Transcriptomics Mechanistic study of Wee1 kinase inhibition with AZD1775 exposes drug targetable vulnerabilities in acute B-lymphoblastic leukemia [scRNA-seq PDX MLL-7]
2023-05-14 | GSE220476 | GEO
Genomics Mechanistic study of Wee1 kinase inhibition with AZD1775 exposes drug targetable vulnerabilities in acute B-lymphoblastic leukemia [scRNA-seq PDX MLL-7]
| PRJNA909828 | ENA
Other Mechanistic study of Wee1 kinase inhibition with AZD1775 exposes drug targetable vulnerabilities in acute B-lymphoblastic leukemia [GROseq]
2023-05-14 | GSE220099 | GEO